In HCC cells, MYC activates the transcription of WDR4, which subsequently enhances the stability and translation of cyclin B1 (CCNB1) mRNA by facilitating binding of eukaryotic initiation factor 2A (EIF2A) to CCNB1 mRNA. The gene discussed is WDR4; the disease is hepatocellular carcinoma.